{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:51:42Z","timestamp":1792039902072,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["06171046"],"award-info":[{"award-number":["06171046"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2701600"],"award-info":[{"award-number":["2021YFC2701600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2701603"],"award-info":[{"award-number":["2021YFC2701603"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.placenta.2025.11.004","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T21:04:00Z","timestamp":1762463040000},"page":"78-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Determination of residue aspirin and its bioactive metabolites in human placenta: Application to high-risk to preeclampsia women received prophylactic low-dose aspirin"],"prefix":"10.1016","volume":"175","author":[{"given":"Kenean Getaneh","family":"Tlaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Pui","family":"Kin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gashaw Garedew","family":"Woldeamanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Wah","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liona C.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Chiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2025.11.004_bib1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(06)68040-9","article-title":"Aspirin resistance","volume":"367","author":"Graeme","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.placenta.2025.11.004_bib2","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1046\/j.1538-7836.2003.00284.x","article-title":"Aspirin resistance: definition, mechanisms and clinical read-outs","volume":"1","author":"Patrono","year":"2003","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.placenta.2025.11.004_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103320","article-title":"Low dose aspirin in high-risk pregnancies: the volatile effect of acetylsalicylic acid on the inhibition of platelets uncovered by G. Born's light transmission aggregometry","volume":"145","author":"Stern","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.placenta.2025.11.004_bib4","series-title":"Acetylsalicylic Acid","author":"Karsten","year":"2022"},{"key":"10.1016\/j.placenta.2025.11.004_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/bj0570301","article-title":"Rapid determination of salicylate in biological fluids","volume":"57","author":"Trinder","year":"1954","journal-title":"Biochem. J."},{"key":"10.1016\/j.placenta.2025.11.004_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0378-4347(97)00539-2","article-title":"Determination of acetylsalicylic acid and salicylic acid in skin and plasma by high-performance liquid chromatography","volume":"705","author":"Pirola","year":"1998","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.placenta.2025.11.004_bib7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0378-4347(95)00464-5","article-title":"Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by high-performance liquid chromatography","volume":"677","author":"Kees","year":"1996","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.placenta.2025.11.004_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00007691-198706000-00020","article-title":"Determination of aspirin and salicylic acid in uremic patients' plasma using reversed-phase high-performance liquid chromatography","volume":"9","author":"Gaspari","year":"1987","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.placenta.2025.11.004_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00007691-198506000-00014","article-title":"A sensitive liquid chromatographic assay for plasma aspirin and salicylate concentrations after low doses of aspirin","volume":"7","author":"Brandon","year":"1985","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.placenta.2025.11.004_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00007691-198010000-00010","article-title":"Measurement and pharmacokinetics of acetylsalicylic acid by a novel high performance liquid chromatographic assay","volume":"2","author":"Elliot","year":"1980","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.placenta.2025.11.004_bib11","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1080\/10826076.2011.589092","article-title":"Simultaneous determination of aspirin and its metabolite from human plasma by UPLC-UV detection: application to pharmacokinetic study","volume":"34","author":"Ghosh","year":"2011","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.placenta.2025.11.004_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1021\/ac9707040","article-title":"Determination of aspirin and salicylic acid in human plasma by column-switching liquid chromatography using On-Line solid-phase extraction","volume":"70","author":"McMahon","year":"1998","journal-title":"Anal. Chem."},{"key":"10.1016\/j.placenta.2025.11.004_bib13","first-page":"527","article-title":"A highly sensitive HPLC method for the simultaneous determination of acetylsalicylic, salicylic and salicyluric acids in biologic fluids: pharmacokinetic, metabolic and monitoring implications","volume":"18","author":"Krivosikova","year":"1996","journal-title":"Methods Find Exp. Clin. Pharmacol."},{"key":"10.1016\/j.placenta.2025.11.004_bib14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/01483919008051818","article-title":"A sensitive assay for aspirin and its metabolites using reversed-phase ion-pair high-performance liquid chromatography","volume":"13","author":"Shen","year":"1990","journal-title":"J. Liq. Chromatogr."},{"key":"10.1016\/j.placenta.2025.11.004_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0378-4347(84)80099-7","article-title":"Rapid and sensitive determination of acetylsalicylic acid and its metabolites using reversed-phase high-performance liquid chromatography","volume":"310","author":"James O'kruk","year":"1984","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.placenta.2025.11.004_bib16","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/jps.2600720913","article-title":"High-performance liquid chromatographic determination of aspirin and its metabolites in plasma and urine","volume":"72","author":"Shamsul","year":"1983","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.placenta.2025.11.004_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0378-4347(00)86135-6","article-title":"Determination of acetylsalicyclic acid and metabolites in biological fluids by high-performance liquid chromatography","volume":"272","author":"Reidl","year":"1983","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.placenta.2025.11.004_bib18","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/bmc.2694","article-title":"Review of HPLC methods and HPLC methods with mass spectrometric detection for direct determination of aspirin with its metabolite(s) in various biological matrices","volume":"26","author":"Mullangi","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.placenta.2025.11.004_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.microc.2016.11.005","article-title":"Robust and sensitive LC\/MS-MS method for simultaneous detection of acetylsalicylic acid and salicylic acid in human plasma","volume":"136","author":"Sirok","year":"2018","journal-title":"Microchem. J."},{"key":"10.1016\/j.placenta.2025.11.004_bib20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.placenta.2015.01.004","article-title":"Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1","volume":"36","author":"Li","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2025.11.004_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jri.2017.10.044","article-title":"The effect of acetyl salicylic acid (aspirin) on trophoblast-endothelial interaction in vitro","volume":"124","author":"Xu","year":"2017","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.placenta.2025.11.004_bib22","doi-asserted-by":"crossref","first-page":"18928","DOI":"10.1002\/jcp.28533","article-title":"Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK\/AP-1 pathway in human trophoblast and endothelial cells","volume":"234","author":"Lin","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.placenta.2025.11.004_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136985","article-title":"The road to low-dose aspirin therapy for the prevention of preeclampsia began with the placenta","volume":"22","author":"Walsh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.placenta.2025.11.004_bib24","article-title":"Bioanalytical method validation","year":"2018","journal-title":"Guidance for Industry"},{"key":"10.1016\/j.placenta.2025.11.004_bib25","first-page":"5","article-title":"Validation of analytical procedures: text and methodology","volume":"1","year":"2005","journal-title":"Q2 (R1)"},{"key":"10.1016\/j.placenta.2025.11.004_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6620868","article-title":"Simultaneous quantification of aspirin, its metabolite salicylic acid, and salvianolic acid B in human plasma using UPLC-MS\/MS","volume":"2021","author":"Cao","year":"2021","journal-title":"Int. J. Analytical Chem."},{"key":"10.1016\/j.placenta.2025.11.004_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89671-w","article-title":"In-vitro and in-vivo metabolism of different aspirin formulations studied by a validated liquid chromatography tandem mass spectrometry method","volume":"11","author":"Dei Cas","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.placenta.2025.11.004_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jchromb.2013.08.024","article-title":"Simultaneous determination of gallic acid and gentisic acid in organic anion transporter expressing cells by liquid chromatography\u2013tandem mass spectrometry","volume":"937","author":"Wang","year":"2013","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.placenta.2025.11.004_bib29","first-page":"589","article-title":"Low dose aspirin estimation: an application to a human pharmacokinetic study","volume":"27","author":"Vijaya Bharathi","year":"2013","journal-title":"Biochem. Chromatography"},{"key":"10.1016\/j.placenta.2025.11.004_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1570-0232(04)00511-2","article-title":"Simultaneous determination of gentisic, salicyluric and salicylic acid in human plasma using solid-phase extraction, liquid chromatography and electrospray ionization mass spectrometry","volume":"809","author":"Pirker","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.placenta.2025.11.004_bib31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/bmc.973","article-title":"Determination of acetylsalicylic acid and its major metabolite, salicylic acid, in human plasma using liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study of astrix in Korean healthy volunteers","volume":"22","author":"Bae","year":"2008","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.placenta.2025.11.004_bib32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/bmc.1209","article-title":"Rapid and sensitive determination of acetylsalicylic acid and salicylic acid in plasma using liquid chromatography\u2013tandem mass spectrometry: application to pharmacokinetic study","volume":"23","author":"Xu","year":"2009","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.placenta.2025.11.004_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/CIRCRESAHA.124.325699","article-title":"Pharmacogenomics and pharmacokinetics of aspirin in preeclampsia prevention","volume":"137","author":"Getaneh Tlaye","year":"2025","journal-title":"Circ. Res."},{"key":"10.1016\/j.placenta.2025.11.004_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.placenta.2025.11.004_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bcp.2019.02.014","article-title":"Characterization of aspirin esterase activity in health and disease: in vitro and ex vivo studies","volume":"163","author":"Porro","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.placenta.2025.11.004_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/00032717908055714","article-title":"Determination of aspirin, salicylic acid, salicyluric acid, and gentisic acid in human plasma and urine by high pressure liquid chromatography","volume":"12","author":"Amick","year":"1979","journal-title":"Anal. Lett."},{"key":"10.1016\/j.placenta.2025.11.004_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/jama.1969.03160170052017","article-title":"Salicylate exposure in the perinate","volume":"209","author":"Palmisano","year":"1969","journal-title":"JAMA"},{"key":"10.1016\/j.placenta.2025.11.004_bib38","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0002-9378(91)90444-V","article-title":"Transfer of aspirin across the perfused human placental cotyledon","volume":"165","author":"Jacobson","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2025.11.004_bib39","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/dmd.106.013029","article-title":"Kinetic analysis of the transport of salicylic acid, a nonsteroidal anti-inflammatory drug, across human placenta","volume":"35","author":"Shintaku","year":"2007","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.placenta.2025.11.004_bib40","first-page":"15","volume":"vol. 233","author":"Wolff","year":"1982"},{"key":"10.1016\/j.placenta.2025.11.004_bib41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000481028","article-title":"Serum protein binding of salicylate during pregnancy and the puerperium","volume":"2","author":"Lovecchio","year":"1981","journal-title":"Dev. Pharmacol. Ther."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425007404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425007404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T07:59:16Z","timestamp":1774857556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400425007404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"alternative-id":["S0143400425007404"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2025.11.004","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of residue aspirin and its bioactive metabolites in human placenta: Application to high-risk to preeclampsia women received prophylactic low-dose aspirin","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2025.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}